(Q67753693)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739915%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739915%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820690516

13 November 2022

author name string

J. C. Bystryn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739915

13 November 2022

R. Oratz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739915

13 November 2022

D. Roses

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739915

13 November 2022

M. Harris

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739915

13 November 2022

M. Henn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739915

13 November 2022

R. Lew

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739915

13 November 2022

language of work or name

English

0 references

publication date

1 March 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739915%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.2820690516

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820690516

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.2820690516

13 November 2022

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820690516

13 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739915%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739915%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739915%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

1157-1164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739915%20AND%20SRC:MED&resulttype=core&format=json

Non-specific and specific active immunotherapy in a B16 murine melanoma system

17 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Specific Active Immunotherapy for Melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Immunogenicity of a polyvalent melanoma antigen vaccine in humans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Chemical xenogenization of experimental tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Comparison of cell-surface human melanoma-associated antigens identified by rabbit and murine antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Immunobiology of primary intracranial tumors. Part 8: Serological responses to active immunization of patients with anaplastic gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820690516

7 January 2021

Preparation and characterization of a polyvalent human melanoma antigen vaccine

8

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820690516

Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide

13 November 2022

9

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820690516

Approaches for the isolation of biologically functional tumor-associated antigens

13 November 2022

29

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820690516

13 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739915%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference